قائمة الطعام
Galena Biopharma, Inc. GALE, -1.86% is a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full ...
NEW YORK, March 28, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against Galena Biopharma, Inc. ("Galena" or the "Company")... SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Galena Biopharma, Inc. of Class Action Lawsuit and Upcoming …
NEW YORK, April 13, 2017 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Galena Biopharma, Inc. ("Galena" or the "Company") (NASDAQ:GALE) and certain of its officers, and is on behalf of purchasers of Galena securities from August 11, …
NEW YORK, April 28, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against Galena Biopharma, Inc. ("Galena" or the "Company")... SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Galena Biopharma, Inc. of Class Action Lawsuit and Upcoming …
December 29, 2017 at 10:16 AM. Galena Biopharma Inc (NASDAQ: GALE) investors have sent shares flying almost 17% this morning following the drug maker's buzz-worthy news: shareholders said yes to ...
IRVINE, CA / ACCESSWIRE / April 4, 2017 / Khang & Khang LLP (the "Firm") announces a class action lawsuit against Galena Biopharma, Inc. ("Galena" or the "Company ...
NEW YORK, April 12, 2017 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Galena Biopharma, Inc. securities (NASDAQ: GALE) from …
Galena Biopharma, Inc. is a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet medical needs.
Overview. Company Description: Key Principal: Hans von Bagh See more contacts. Industry: Pharmaceutical and Medicine Manufacturing, Chemical Manufacturing, …
SELLAS Life Sciences Group, Inc. – Marks an End to All Litigation Related to Activities of SELLAS' Predecessor, Galena Biopharma –. NEW YORK, Feb. 28, 2022 (GLOBE NEWSWIRE) -- SELLAS Life ...
Galena Biopharma, Inc. is a biopharmaceutical company that focuses on developing oncology treatments to address major unmet medical needs to advance cancer care.
About us. Galena Pharma – A Forerunner in MDR Compliance We are a leading Finnish CDMO specializing in developing, manufacturing, and life cycle management of a wide …
SELLAS Life Sciences Announces Final Court Approval of Settlement of Securities Litigation. 02/28/22. Download this Press Release (PDF) – Marks an End to …
NEW YORK, April 13, 2017 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Galena Biopharma, Inc ...
About Galena Biopharma. Galena Biopharma, Inc. is a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs. Galena's pipeline consists of ...
Galena Biopharma Announces NeuVax(TM) (E75) Improves Disease-Free Survival at 60-Month Median Follow-Up - The combined SN-33 (Node Positive) (n=97) and SN-34 (Node Negative) (n=90) Intent-to-treat ...
Galena Biopharma, Inc. is a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs. Galena's pipeline consists of multiple mid-to-late-stage clinical assets led by its hematology asset, GALE-401, and its novel cancer immunotherapy programs including NeuVax™ …
Galena Biopharma is a biotechnology company focused on discovering, developing, and commercializing innovative therapies addressing major unmet medical needs using targeted …
NEW YORK, March 6, 2014 /PRNewswire/ -- Bernstein Liebhard LLP today announced that a class action has been commenced in the United States District Court for the District of …
San Ramon, California, December 8, 2017 — Galena Biopharma, Inc. (NASDAQ: GALE), would like to remind stockholders to vote their respective shares and support the …
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against GALENA BIOPHARMA, INC. and Its Board and a Lead Plaintiff Deadline of May 5, 2014 -- GALE March 20, 2014 18:10 ET ...
Galena Biopharma Inc. (Galena) will pay more than $7.55 million to resolve allegations under the civil False Claims Act that it paid kickbacks to doctors to induce them to prescribe its fentanyl-based drug Abstral, the Department of Justice announced today. "Given the dangers associated with opioids such as Abstral, it is imperative that …
SAN RAMON, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ: GALE) would like to remind stockholders to vote their …
The all-time high Galena Biopharma stock closing price was 408000.41 on March 13, 2008. The Galena Biopharma 52-week high stock price is 1.91, which is 37.4% above the current share price. The Galena Biopharma 52-week low stock price is 0.50, which is 64% below the current share price. The average Galena Biopharma stock price for the last 52 ...
Analyst Recommendations on Galena Biopharma Inc. Cantor Fitzgerald Adjusts Price Target on SELLAS Life Sciences Group to $6 From $10, Keeps Overweight Rating. 22-06-28. MT. Alliance Global Adjusts Price Target on SELLAS Life Sciences Group to $14 From $16.50, Reiterates Buy Rating. 22-04-08.
Deadline Alert: GPM Reminds Investors of the April 14 Deadline in the Class Action Lawsuit Against Galena Biopharma, Inc. April 05, 2017 01:52 PM Eastern Daylight Time
SAN RAMON, Calif., Dec. 08, 2017 -- Galena Biopharma, Inc. would like to remind stockholders to vote their respective shares and support the business combination transaction with SELLAS Life... | January 25, 2023
Open Int (30-Day): The average total open interest for all option contracts (across all expiration dates) for the last 30 days. Galena Biopharma In stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.
Welcome to the Settlement website for the Galena Biopharma, Inc., Securities Litigation (the "Action") PLEASE READ – IMPORTANT: On January 23, 2023, the Court issued an …
The Rosen Law Firm, P.A. today reminds all purchasers of the common stock of Galena Biopharma, Inc. between November 6, 2013 and February 14, 2014, inclusive of the important May 5, 2014 lead ...
حقوق النشر ©2000- 2024 شركة شنغهاي زينيث
